261 related articles for article (PubMed ID: 18665975)
1. Botulinum toxin: future developments.
De Ridder D
BJU Int; 2008 Jul; 102 Suppl 1():20-2. PubMed ID: 18665975
[TBL] [Abstract][Full Text] [Related]
2. The use of botulinum toxin type A in urological procedures.
Lajiness MJ
Urol Nurs; 2009; 29(6):445-50. PubMed ID: 20088238
[TBL] [Abstract][Full Text] [Related]
3. The case for bladder botulinum toxin application.
Kim DK; Thomas CA; Smith C; Chancellor MB
Urol Clin North Am; 2006 Nov; 33(4):503-10, ix. PubMed ID: 17011386
[TBL] [Abstract][Full Text] [Related]
4. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
Schmid DM; Roy S; Sulser T; Scheiner D
BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
[TBL] [Abstract][Full Text] [Related]
5. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?
da Silva CM; Cruz F
Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity.
Drake MJ
BJU Int; 2008 Jul; 102 Suppl 1():11-6. PubMed ID: 18665973
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
Pannek J; Göcking K; Bersch U
BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
[TBL] [Abstract][Full Text] [Related]
8. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
9. Botulinum-A toxin: an exciting new treatment option for prostatic disease.
Thomas CA; Guercini F; Chuang YC; Chancellor MB
Int J Clin Pract Suppl; 2006 Dec; (151):33-7. PubMed ID: 17169009
[TBL] [Abstract][Full Text] [Related]
10. Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity.
Sangster P; Kalsi V
BJU Int; 2008 Jul; 102 Suppl 1():17-9. PubMed ID: 18665974
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin injection therapy in the management of lower urinary tract dysfunction.
Patel AK; Chapple CR
Int J Clin Pract Suppl; 2006 Dec; (151):1-7. PubMed ID: 17169004
[TBL] [Abstract][Full Text] [Related]
12. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
Giannantoni A; Mearini E; Del Zingaro M; Santaniello F; Porena M
BJU Int; 2008 Jul; 102 Suppl 1():2-6. PubMed ID: 18665971
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
14. Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results.
Karsenty G; Baazeem A; Elzayat E; Corcos J
Can J Urol; 2006 Apr; 13(2):3027-33. PubMed ID: 16672114
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
Haferkamp A
Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561
[No Abstract] [Full Text] [Related]
16. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes.
Chuang YC; Tyagi P; Huang CC; Yoshimura N; Wu M; Kaufman J; Chancellor MB
J Urol; 2009 Aug; 182(2):786-92. PubMed ID: 19539320
[TBL] [Abstract][Full Text] [Related]
17. [Use of botulinum toxin in urology].
Jost WH
Nervenarzt; 2008 Jun; 79 Suppl 1():29-32. PubMed ID: 18927963
[TBL] [Abstract][Full Text] [Related]
18. Novel cutaneous uses for botulinum toxin type A.
Bansal C; Omlin KJ; Hayes CM; Rohrer TE
J Cosmet Dermatol; 2006 Sep; 5(3):268-72. PubMed ID: 17177750
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Antunes AA; Srougi M; Coelho RF; de Campos Freire G
Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in the treatment of OAB, BPH, and IC.
Smith CP
Toxicon; 2009 Oct; 54(5):639-46. PubMed ID: 19268490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
